A carregar...

Guide to Interpreting Disease Responses in Chronic Myeloid Leukemia

With the introduction of tyrosine kinase inhibitor (TKI) therapy for chronic myeloid leukemia, the course of the disease has been altered from an acute, rapidly progressive terminal disorder to a serious condition with high remission rates when patients are compliant with long-term treatment. The go...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Galinsky, Ilene, Buchanan, Susan
Formato: Artigo
Idioma:Inglês
Publicado em: Harborside Press 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4093342/
https://ncbi.nlm.nih.gov/pubmed/25031950
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!